PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.

TitlePDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.
Publication TypeJournal Article
Year of Publication2017
AuthorsMeehan TF, Conte N, Goldstein T, Inghirami G, Murakami MA, Brabetz S, Gu Z, Wiser JA, Dunn P, Begley DA, Krupke DM, Bertotti A, Bruna A, Brush MH, Byrne AT, Caldas C, Christie AL, Clark DA, Dowst H, Dry JR, Doroshow JH, Duchamp O, Evrard YA, Ferretti S, Frese KK, Goodwin NC, Greenawalt D, Haendel MA, Hermans E, Houghton PJ, Jonkers J, Kemper K, Khor TO, Lewis MT, Lloyd KCKent, Mason J, Medico E, Neuhauser SB, Olson JM, Peeper DS, Rueda OM, Seong JKyung, Trusolino L, Vinolo E, Wechsler-Reya RJ, Weinstock DM, Welm A, S Weroha J, Amant F, Pfister SM, Kool M, Parkinson H, Butte AJ, Bult CJ
JournalCancer Res
Volume77
Issue21
Paginatione62-e66
Date Published2017 11 01
ISSN1538-7445
KeywordsAnimals, Databases as Topic, Disease Models, Animal, Humans, Mice, Neoplasms, Patients, Xenograft Model Antitumor Assays
Abstract

Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. .

DOI10.1158/0008-5472.CAN-17-0582
Alternate JournalCancer Res
PubMed ID29092942
PubMed Central IDPMC5738926
Grant ListL30 CA188976 / CA / NCI NIH HHS / United States
T32 CA009172 / CA / NCI NIH HHS / United States
HHSN261200800001E / CA / NCI NIH HHS / United States
U24 CA204781 / CA / NCI NIH HHS / United States
U24 CA195858 / CA / NCI NIH HHS / United States
R01 CA089713 / CA / NCI NIH HHS / United States
P30 CA034196 / CA / NCI NIH HHS / United States
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700